标题
Anti-obesity drugs: a review about their effects and their safety
作者
关键词
-
出版物
Expert Opinion On Drug Safety
Volume 11, Issue 3, Pages 459-471
出版商
Informa Healthcare
发表日期
2012-03-24
DOI
10.1517/14740338.2012.675326
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Effects of One Year Treatment of Sibutramine on Insulin Resistance Parameters in Type 2 Diabetic Patients
- (2016) Giuseppe Derosa et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- L-Carnitine - Metabolic Functions and Meaning in Humans Life
- (2011) Jolanta Pekala et al. CURRENT DRUG METABOLISM
- Exenatide or glimepiride added to metformin on metabolic control and on insulin resistance in type 2 diabetic patients
- (2011) Giuseppe Derosa et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Effects of 1-year orlistat treatment compared to placebo on insulin resistance parameters in patients with type 2 diabetes
- (2011) G. Derosa et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity
- (2010) J. G. Kang et al. DIABETES OBESITY & METABOLISM
- Exenatide Versus Glibenclamide in Patients with Diabetes
- (2010) G. Derosa et al. Diabetes Technology & Therapeutics
- Orlistat and L-carnitine compared to orlistat alone on insulin resistance in obese diabetic patients
- (2010) Giuseppe Derosa et al. ENDOCRINE JOURNAL
- Comparison of orlistat treatment and placebo in obese type 2 diabetic patients
- (2010) Giuseppe Derosa et al. EXPERT OPINION ON PHARMACOTHERAPY
- Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients
- (2010) Giuseppe Derosa et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Sibutramine and L-Carnitine Compared to Sibutramine Alone on Insulin Resistance in Diabetic Patients
- (2010) Giuseppe Derosa et al. INTERNAL MEDICINE
- Variation of inflammatory parameters after sibutramine treatment compared to placebo in type 2 diabetic patients
- (2010) G. Derosa et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Effects of combination of sibutramine and l-carnitine compared with sibutramine monotherapy on inflammatory parameters in diabetic patients
- (2010) Giuseppe Derosa et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
- (2010) W. Philip T. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period
- (2010) Peter Weeke et al. BMC Endocrine Disorders
- An Endocannabinoid Hypothesis of Drug Reward and Drug Addiction
- (2009) Emmanuel S. Onaivi Annals of the New York Academy of Sciences
- The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis
- (2009) Daphne P Guh et al. BMC PUBLIC HEALTH
- Comparison of the effects of sibutramine versus sibutramine plus metformin in obese women
- (2009) Ramazan Sari et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Orlistat 120 mg improves glycaemic control in type 2 diabetic patients with or without concurrent weight loss
- (2009) S. Jacob et al. DIABETES OBESITY & METABOLISM
- Weight and blood pressure response to weight management and sibutramine in diabetic and non-diabetic high-risk patients: an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes (SCOUT) trial
- (2009) L. F. Van Gaal et al. DIABETES OBESITY & METABOLISM
- Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis
- (2009) David R Janero et al. EXPERT OPINION ON EMERGING DRUGS
- Early Response to Sibutramine in Patients Not Meeting Current Label Criteria: Preliminary Analysis of SCOUT Lead-in Period
- (2009) Ian Caterson et al. Obesity
- SERENADE: The Study Evaluating Rimonabant Efficacy in Drug-Naive Diabetic Patients: Effects of monotherapy with rimonabant, the first selective CB1 receptor antagonist, on glycemic control, body weight, and lipid profile in drug-naive type 2 diabetes
- (2008) J. Rosenstock et al. DIABETES CARE
- Endocannabinoids and the Control of Energy Homeostasis
- (2008) George Kunos et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone
- (2008) Giuseppe Derosa et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Methylphenidate Hydrochloride Increases Energy Expenditure in Healthy Adults
- (2008) Claudio Lorello et al. Obesity
- Weight Loss Produced by Tesofensine in Patients With Parkinson's or Alzheimer's Disease
- (2008) Arne Astrup et al. Obesity
- Rimonabant and Depression
- (2008) M. Soyka PHARMACOPSYCHIATRY
- The Obesity Paradox: Impact of Obesity on the Prevalence and Prognosis of Cardiovascular Diseases
- (2008) Surya M. Artham et al. POSTGRADUATE MEDICINE
- Elevated body mass index and fatty liver
- (2008) Dragana Marovic Srpski Arhiv za Celokupno Lekarstvo
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now